Comparison of performance of cervical cancer grading based on acetowhite areas.

Sci Rep

Department of Biohealth & Medical Engineering, Gachon University, Seongnam, Republic of Korea.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cervical cancer ranks fourth globally in terms of both incidence and mortality among women, making timely diagnosis essential for effective treatment. Although the acetowhite regions and their margins are important for cervical cancer staging, their potential for automated cancer grading remains underexplored. This study aimed to enhance diagnostic accuracy and grading precision by effectively analyzing the acetowhite region and its surroundings. Using four classifiers (Logistic Regression(LR), Random Forest(RF), XGBoost(XGB), and Support Vector Machine(SVM)), 464 cervical images (228 atypical and 236 positive cases) were analyzed. From a set of 75 features, the classifiers identified the top 5 based on feature importance. Receiver Operating Characteristic (ROC) analysis yielded the following precisions for models trained with masks containing only the acetowhite lesion: LR 0.80 (CI 95% 0.70-0.90), SVM 0.83 (CI 95% 0.75-0.92), RF 0.79 (CI 95% 0.69-0.89), XGB 0.66 (CI 95% 0.55-0.77). For models trained with masks including the acetowhite lesion and a 10-pixel margin: LR 0.79 (CI 95% 0.70-0.88), SVM 0.87 (CI 95% 0.78-0.95), RF 0.86 (CI 95% 0.77-0.94), XGB 0.84 (CI 95% 0.75-0.93). Our findings indicate that including a 10-pixel margin around acetowhite lesions improves classifier performance, suggesting its advantage in the automated classification of cervical images.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317971PMC
http://dx.doi.org/10.1038/s41598-025-13205-xDOI Listing

Publication Analysis

Top Keywords

cervical cancer
12
cancer grading
8
cervical images
8
models trained
8
trained masks
8
acetowhite lesion
8
95%
8
079 95%
8
10-pixel margin
8
acetowhite
6

Similar Publications

The Future of Cervical Cancer Screening Is Now.

Obstet Gynecol

July 2025

Ana I. Tergas is from the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Newark, New Jersey. Mark H. Einstein is from the Department of Obstetrics, Gynecology, and Women's Health, Albert Einstein College of Medicine

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) represent a promising therapeutic approach in gynecologic cancers, particularly ovarian and cervical malignancies. Agents such as mirvetuximab soravtansine, and tisotumab vedotin, targeting folate receptor alpha and tissue factor, respectively, reported clinical efficacy in patients with limited options. However, their use is associated with ocular toxicities, including keratopathy, blurred vision, and dry eye, which may impact adherence and quality of life.

View Article and Find Full Text PDF

Pterostilbene as a promising natural anticancer agent in gynecological cancers.

Med Oncol

September 2025

Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.

Gynecological cancer, encompassing cancers such as endometrial and cervical cancer, is a growing concern worldwide, with a rising incidence and significant impact on women's health. Pterostilbene (PT), a natural compound, has shown promising therapeutic potential in gynecological cancer treatment. This review aims to summarize the current state of knowledge on PT's effects in gynecological cancer, focusing on its molecular mechanisms, preclinical studies, and clinical trials.

View Article and Find Full Text PDF

Background: High-dose-rate (HDR) brachytherapy is essential in the treatment of locally advanced cervical cancer. While Iridium-192 (Ir-192) is commonly used, its short half-life imposes logistical and financial constraints, particularly in low- and middle-income countries (LMICs). Cobalt-60 (Co-60), with a longer half-life and lower operational costs, is a viable alternative.

View Article and Find Full Text PDF

Human papillomavirus (HPV) causes multiple diseases in both sexes. This study evaluates the cost-effectiveness and epidemiological impact - defined as reductions in HPV-related disease cases - of a gender-neutral vaccination (GNV) strategy in China's economically developed metropolises: Beijing, Shanghai, and Guangzhou. A discrete-time Markov model simulated no vaccination, female-only vaccination (FOV), and GNV strategies among 12-year-olds.

View Article and Find Full Text PDF